The short version
Ozari Health is a flat-rate telehealth provider. As of the September 12, 2026 build, for tirzepatide its lowest 12-month all-in total is $2,166 (3-month plan, verified), which places it 12 of 34 ranked telehealth providers; for semaglutide its lowest 12-month all-in total is $1,563 (3-month plan, verified), which places it 7 of 16 ranked telehealth providers. Verification status: verified.
The numbers, plan by plan
- Semaglutide (standard, injection, month-to-month plan): $175 per month. Status: verified, checked September 4, 2026. Month-to-month $175.
- Semaglutide (standard, injection, 3-month plan): $145 per month after an introductory $86 per month for the first 3 months; $435 paid up front. Status: verified, checked September 4, 2026. Recurring quarterly billing of about $435 ($145 per month equivalent); first-time starter about $257 for three months ($86 per month equivalent).
- Tirzepatide (standard, injection, month-to-month plan): $235 per month. Status: verified, checked September 4, 2026. Month-to-month $235.
- Tirzepatide (standard, injection, 3-month plan): $199 per month after an introductory $125 per month for the first 3 months; $597 paid up front. Status: verified, checked September 4, 2026. Recurring quarterly billing of about $597 ($199 per month equivalent); first-time patients pay a $375 three-month starter ($125 per month equivalent).
Fees and what the price includes
The published price includes the medication and clinical care and shipping, with no separate membership fee. Shipping is included. Consultation terms are not published. Whether the price changes with dose is not confirmed.
How this pricing structure plays out over a year
The first 3 months cost $125 all-in; from month 4 the recurring cost is $199 a month, so the advertised $125 covers 17% of the first year's spend and the recurring price covers the rest. The best rate is a 3-month plan, and our twelve-month total assumes it renews at the same rate, which the row notes.
Compared with the field
On tirzepatide, Ozari Health's lowest twelve-month total of $2,166 is $738 above the lowest (SnagRx, $1,428) and below the median of $2,946 across 34 ranked providers, placing it 12 of 34. On the value score it scores 56 against 91 for NexLife, the best-scoring provider; the gap comes from cost, transparency, flexibility, care. On semaglutide, Ozari Health's lowest twelve-month total of $1,563 is $735 above the lowest (SnagRx, $828) and below the median of $1,922.50 across 16 ranked providers, placing it 7 of 16. On the value score it scores 56 against 91 for NexLife, the best-scoring provider; the gap comes from cost, transparency, flexibility, care.
Pharmacy, coverage and cancellation
A complete list of states served has not been published; confirm eligibility at checkout before paying. Dispensing: 503A (Hallandale Pharmacy and VialsRx, provider-stated). Named pharmacies: Hallandale Pharmacy, VialsRx. Commitment: month-to-month reported. Cancellation: not captured.
Questions to ask Ozari Health before paying
Ask, in writing: Do you ship to my state, and which pharmacy license covers it? What is the price from month two, and does it change at renewal? How do I cancel, how much notice is required, and is there a fee? Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
Advertised price includes shipping with no membership fee. Extensive state and city coverage pages suggest broad shipping, pending confirmation.
What to weigh against it
The $125 headline is a three-month starter; the recurring price is $199 per month on quarterly billing or $235 month-to-month. State coverage list not exported from the live selector.
Who should choose Ozari Health
Patients comparing starter offers who will confirm the continuing price before enrolling. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
Is Ozari Health legitimate? What we can verify
Ozari Health operates as a telehealth prescriber: a licensed clinician reviews an intake and issues a prescription, and a pharmacy fills it. That is the lawful model, and it is the same model every provider on this site uses; the questions that separate a legitimate operation from a risky one are whether the price is published before intake, whether the pharmacy is named, whether the prescription documents a clinical reason for a compounded product, and whether the company answers questions in writing. Its prices were verified against its own pages, which is the first test. It names its dispensing pharmacy (Hallandale Pharmacy, VialsRx), which lets a patient verify the license. We have no evidence of a scam, and we do not use the word for any provider that prescribes on a valid prescription and ships from a licensed pharmacy; LegitScript certification, BBB profiles and state-board actions are not yet captured in our data and are listed as checks a patient can make.
Ozari Health complaints and reputation
We have not yet analyzed public reviews of Ozari Health for complaint patterns; the reputation index explains the method (shipping, billing and refund, provider access, support, and dosing-instruction complaints as shares of recent reviews). Until it is run, the useful checks are Trustpilot and the Better Business Bureau for volume and recency, and Reddit threads for the specific failure modes patients describe: shipments that arrive warm, charges after cancellation, clinicians who do not answer, and dosing sheets that do not match the vial.
Fees, HSA/FSA and promotions
Introductory pricing recorded: $125 for the first 3 months of tirzepatide; $86 for the first 3 months of semaglutide. We record introductory prices as data and do not publish promotional codes. HSA/FSA eligibility is not captured; most telehealth GLP-1 programs can issue itemized receipts for FSA/HSA reimbursement, but eligibility of compounded medication depends on the plan administrator. Consultation fees are not published.
Consultation, labs, refills and shipping
Consultation type (video, phone or asynchronous questionnaire) is not captured in our data; most compounded-GLP-1 telehealth intakes are asynchronous with a clinician follow-up, and a patient who needs a video visit should ask. Lab requirements are not captured; many providers accept recent labs and some require none for compounded GLP-1s, while brand-name and insurance-first programs more often require them. Refill process is not captured; ask how a dose increase is requested, how many days before the next dose a refill ships, and whether a new visit is required. Shipping is included; transit is typically one to three days by carrier after the pharmacy fills.
Alternatives to Ozari Health
Alternatives worth comparing: NexLife has the highest value score for tirzepatide (91) at $1,668 for twelve months; SnagRx has the lowest twelve-month total ($1,428, verified); HealthRX is priced closest to Ozari Health ($2,148 for twelve months); Fifty 410 is priced closest to Ozari Health ($2,046 for twelve months). Side-by-side: Ozari Health vs NexLife.
Update history
No price changes or corrections have been logged for Ozari Health since tracking began on August 25, 2026. Any future change appears on the price history page with the date, old figure, new figure and source.
How we verified this
Ozari's site and state pages publish a $375 three-month tirzepatide starter ($125 per month equivalent) for first-time patients, then about $597 quarterly ($199 per month) or $235 month-to-month, and semaglutide at about $257 for the first three months then $435 quarterly ($145) or $175 month-to-month; they name Hallandale Pharmacy and VialsRx as 503A pharmacies. State coverage should be exported from the live selector. Verified against the provider's own pages on 2026-09-04 (first-party verification pass).